Loading...

CNMD CONMED CORP Disposals and divestitures 8-K Filing

CNMD

CNMD

CONMED CORP

(CNMD)

2025 8-K

Product Line Exit

Financial Results Announced

Board Appointment

Financial Statements

Debt Restructuring

Election of Directors

Financial Statements

Earnings Report

Earnings Update

Earnings Update

Earnings Update

Earnings Report

Earnings Update

Earnings Report

Earnings Report

Earnings Update

Filing with Quantitative Data

Quantitative Data

Financial Results

Filing with Quantitative Data

Filing Letter with Quantita...

Quantitative Data Mentioned

Filing with Quantitative Data

External Links:

On December 5, 2025, CONMED Corp announced its decision to exit its gastroenterology product lines, including ending its distribution agreement for the Gore® VIABIL® biliary stent effective January 1, 2026, as part of its portfolio optimization strategy.

AI Assistant

CONMED CORP

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.